BZYR
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Apr 24 closing price
Capitalization
4.6M
SPRB
Price
$0.14
Change
+$0.01 (+7.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
5.9M
12 days until earnings call
Ad is loading...

BZYR vs SPRB

Header iconBZYR vs SPRB Comparison
Open Charts BZYR vs SPRBBanner chart's image
Burzynski Research Institute
Price$0.04
Change-$0.01 (-20.00%)
Volume$29.93K
Capitalization4.6M
Spruce Biosciences
Price$0.14
Change+$0.01 (+7.69%)
Volume$75.11K
Capitalization5.9M
BZYR vs SPRB Comparison Chart
Loading...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BZYR vs. SPRB commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BZYR is a Hold and SPRB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BZYR: $0.04 vs. SPRB: $0.14)
Brand notoriety: BZYR and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BZYR: 251% vs. SPRB: 180%
Market capitalization -- BZYR: $4.6M vs. SPRB: $5.9M
BZYR [@Biotechnology] is valued at $4.6M. SPRB’s [@Biotechnology] market capitalization is $5.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BZYR’s FA Score shows that 0 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • BZYR’s FA Score: 0 green, 5 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, both BZYR and SPRB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRB’s TA Score shows that 4 TA indicator(s) are bullish.

  • SPRB’s TA Score: 4 bullish, 4 bearish.

Price Growth

BZYR (@Biotechnology) experienced а -22.22% price change this week, while SPRB (@Biotechnology) price change was +17.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BZYR is expected to report earnings on Jan 13, 2023.

SPRB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRB($5.9M) has a higher market cap than BZYR($4.6M). BZYR YTD gains are higher at: 12.903 vs. SPRB (-66.690). BZYR has higher annual earnings (EBITDA): -1.46M vs. SPRB (-39.02M). SPRB has more cash in the bank: 60.1M vs. BZYR (613). SPRB has higher revenues than BZYR: SPRB (7.1M) vs BZYR (0).
BZYRSPRBBZYR / SPRB
Capitalization4.6M5.9M78%
EBITDA-1.46M-39.02M4%
Gain YTD12.903-66.690-19%
P/E RatioN/AN/A-
Revenue07.1M-
Total Cash61360.1M0%
Total DebtN/A3.23M-
FUNDAMENTALS RATINGS
BZYR: Fundamental Ratings
BZYR
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPRB
RSI
ODDS (%)
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRNC8.930.76
+9.30%
Cerence
PAY31.140.95
+3.15%
Paymentus Holdings
IP47.630.88
+1.88%
International Paper Co
FONR12.20N/A
N/A
Fonar Corp
SILO1.14-0.02
-1.73%
Silo Pharma

BZYR and

Correlation & Price change

A.I.dvisor tells us that BZYR and DWTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BZYR and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BZYR
1D Price
Change %
BZYR100%
-22.22%
DWTX - BZYR
29%
Poorly correlated
-3.58%
SPRB - BZYR
24%
Poorly correlated
+5.27%
CRNX - BZYR
21%
Poorly correlated
+3.15%
RENB - BZYR
20%
Poorly correlated
-0.75%
BVNRY - BZYR
10%
Poorly correlated
-0.45%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MTVA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+5.27%
MTVA - SPRB
66%
Loosely correlated
+4.55%
IMRX - SPRB
52%
Loosely correlated
+3.55%
MLEC - SPRB
51%
Loosely correlated
-5.13%
SCPX - SPRB
43%
Loosely correlated
-8.70%
GNFT - SPRB
39%
Loosely correlated
+0.78%
More